A Center of Biomedical Research Excellence

The Vermont Lung Center (VLC), a Program on Lung Biology and Disease, has been in existence at the Robert Larner, M.D. College of Medicine at the University of Vermont since 1972. It has had a rich and productive past that has had a significant impact nationally. The current program centers around a COBRE award from the National Institute of General Medical Sciences (NIGMS) of the NIH. The keystone to the VLC program is translational research. The goals of the VLC are to investigate the mechanisms of lung biology and disease, and to train and retain outstanding translational scientists at UVM. Our key product is excellence.


Chest x-ray viewing

Research Training

The VLC has been established as a regional focal point for education. A series of education programs are being offered that target a varied audience including patients, parents/guardians of patients, health care professionals, the academic community, and the general public.

Checking blood pressure

Clinical Trials

Care of patients with lung disease presents a number of unique problems for optimal healthcare delivery, particularly in the rural setting of Vermont. Our goal is to establish the Lung Center as the regional point of expertise, referral and quality patient care.

VT Lung in the News

 

Vermont Lung Center Logo

Irvin & Colleagues Flavored E-Cigs & Asthma Study Covered by National Media Outlets

October 16, 2019 by Jennifer Nachbur

(OCTOBER 15, 2019) Several news outlets recently covered a research study on flavored e-cigarettes and asthma published in Nature Scientific Reports by Larner faculty and trainees, including senior author and Professor of Medicine Charles Irvin, Ph.D. The study was funded through UVM's Tobacco Center on Regulatory Science (TCORS) grant.

(OCTOBER 15, 2019) Several news outlets recently covered a research study on flavored e-cigarettes and asthma published in Nature Scientific Reports by Larner faculty and trainees, including senior author and Professor of Medicine Charles Irvin, Ph.D. The study, funded through UVM's Tobacco Center on Regulatory Science (TCORS) grant, was featured in U.S. News & World Report/HealthDay; Healio PulmonologyAmerican Journal of Managed Care;Medical News Bulletin; and Medical Daily.